Nuevelution take out read-accross22 May 2019 16:13
Sareum investors might be interested to note the $160m valuation placed on Nuevelution (Swedish biotech, subject to a takeover announced today by Amgen), which has a pipeline with ~4 preclin assets (one partnered, see https://nuevolution.com/pipelines/programs/ ) for immune/inflam indications, all potentially adressable with a Tyk2 inhib.